Johnson & Johnson's Fiscal Year is From January To December.
The item "Receivables-Turnover" stands at 5.24 as of 09/30/2025, the lowest value since 06/30/2024.
As of the end of Johnson & Johnson's third quarter, the item "Receivables Turnover" stands at 5.24. This represents a decrease of -0.4 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -1.05 percent compared to the value the year prior.
The 1 year change in percent is -1.05.
The 3 year change in percent is -9.23.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Receivables Turnover | 905,699,262,464.00 |
![]() | AbbVie Inc - Receivables Turnover | 399,570,305,024.00 |
![]() | Roche Holding AG - Receivables Turnover | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Receivables Turnover | 280,205,508,085.11 |
![]() | Novartis AG - Receivables Turnover | 255,096,620,580.91 |